sabine ducret

Worked on a phase IV study in schizophrenia.

* Working on international clinical trials in phases II and III from initial regulatory submissions to close out visits. * Negotiation of financial agreements with sites. * Therapeutic areas : oncology (ovarian cancer, lymphoma, melanoma....), infectious disease (HIV, severe sepsis), neurology ... * Junior CRAs mentoring

* Management of all aspects of clinical start up activities in European countries to achieve successful activation of sites within timeline and according to budget. * Coordination of site selection, ethic and regulatory submissions, contracts negotiation and IP pack release. * International clinical trials from phase I to phase III in various therapeutic areas.

At PRA Health Sciences, providing innovative solutions for our clients is what we do. Side-by-side with our clients, we strive to move drug discovery forward, helping them to develop life-saving and life-improving drugs. PRA has more than 12,000 employees working in 80+ countries providing comprehensive clinical development services across all phases. From full service clinical development to the pioneering Embedded Solutions™ model, PRA provides a broad spectrum of solutions that meet the demands of a diverse marketplace. As a top five CRO, we have worked on 100+ marketed drugs across several therapeutic areas and conducted the pivotal or supportive trials that led to FDA and/or international regulatory approval of 50+ such drugs.